The program aims to bolster domestic biomanufacturing and supply chain capabilities and speed point-of-care therapeutics production.
The Dow Jones Industrial Average rose 1 percent month over month, the Nasdaq rose 4 percent, and the Nasdaq Biotech Index rose 10 percent.
A polygenic risk score provided insights into hypertrophic cardiomyopathy risk and adverse cardiovascular outcomes in individuals with or without Mendelian disease contributors.
With ongoing reagent challenges postponing its proteome-scale ambitions indefinitely, the firm has shifted the majority of its R&D resources to developing its targeted technology.
Top Five Articles Last Week: Antibody Image Manipulation, Guardant Health to Pay $245M Damages, More
Last week, GenomeWeb’s readers were most interested in learning about a new report suggesting manipulation of antibody validation images is widespread among providers.
NEW YORK – Following the recent controversy that Thermo Fisher Scientific had used hundreds of apparently doctored validation images for its online antibody catalog, a new report indicates that data ...
Newly Discovered 'PCR Leaping' Artifact Could be Useful for Bacterial Gene Screening Oxford Nanopore Lays Out Strategy to Capture Biopharma, Clinical Business Opportunities US Court of Appeals Sides ...
NEW YORK – Drug developer ProFound Therapeutics said it has received an investment of up to $35 million from the Gates Foundation to identify biomarkers, drug targets, and drug candidates for ...
NEW YORK — Laboratory automation firm Copia Scientific said this week that it has signed an agreement to distribute certain of Hombrechtikon Systems Engineering's (HSE) nucleic acid measurement ...
Pillar Biosciences and Hamilton have released an automated next-generation sequencing library prep workflow for the OncoReveal Nexus 21 gene panel, which is designed to interrogate 21 genes relevant ...
Pillar Biosciences and Hamilton have released an automated next-generation sequencing library prep workflow for the OncoReveal Nexus 21 gene panel, which is designed to interrogate 21 genes relevant ...
NEW YORK – A jury in the US District Court for the District of Delaware found that Parse Biosciences, a subsidiary of Qiagen, willfully infringed three patents belonging to Scale Biosciences, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results